Literature DB >> 14002455

Thalidomide and congenital abnormalities.

T J YANG, T S YANG, H M LIANG.   

Abstract

Entities:  

Keywords:  ABNORMALITIES; THALIDOMIDE

Mesh：

Substances：

Year:  1963        PMID： 14002455     DOI： 10.1016/s0140-6736(63)91347-3

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

1.  Phase II study of doxorubicin and thalidomide in patients with refractory aggressive fibromatosis.

Authors:  Xin Liu; Huijie Wang; Xianghua Wu; Xiaonan Hong; Zhiguo Luo
Journal:  Invest New Drugs       Date:  2017-11-23       Impact factor: 3.850

Review 2.  Novel immunomodulatory drugs and neo-substrates.

Authors:  Shaobing Gao; Shichao Wang; Yongping Song
Journal:  Biomark Res       Date:  2020-01-09

3.  Medication Use During Pregnancy in Mainland China: A Cross-Sectional Analysis of a National Health Insurance Database.

Authors:  Jingyuan Zhang; Carolina Oi Lam Ung; Anita Katharina Wagner; Xiaodong Guan; Luwen Shi
Journal:  Clin Epidemiol       Date:  2019-12-10       Impact factor: 4.790

4.  Investigating drug repositioning opportunities in FDA drug labels through topic modeling.

Authors:  Halil Bisgin; Zhichao Liu; Reagan Kelly; Hong Fang; Xiaowei Xu; Weida Tong
Journal:  BMC Bioinformatics       Date:  2012-09-11       Impact factor: 3.169

5.  Safety of medication use during pregnancy in mainland China: based on a national health insurance database in 2015.

Authors:  Jingyuan Zhang; Carolina Oi Lam Ung; Xiaodong Guan; Luwen Shi
Journal:  BMC Pregnancy Childbirth       Date:  2019-12-03       Impact factor: 3.007
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.